You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 13, 2025

Drug Price Trends for NDC 00591-2474


✉ Email this page to a colleague

« Back to Dashboard


Average Pharmacy Cost for 00591-2474

Drug Name NDC Price/Unit ($) Unit Date
TETRACYCLINE 250 MG CAPSULE 00591-2474-01 0.52768 EACH 2024-12-18
TETRACYCLINE 250 MG CAPSULE 00591-2474-01 0.60904 EACH 2024-11-20
TETRACYCLINE 250 MG CAPSULE 00591-2474-01 0.59948 EACH 2024-10-23
TETRACYCLINE 250 MG CAPSULE 00591-2474-01 0.67994 EACH 2024-09-18
TETRACYCLINE 250 MG CAPSULE 00591-2474-01 0.45051 EACH 2024-08-21
TETRACYCLINE 250 MG CAPSULE 00591-2474-01 0.69973 EACH 2024-07-17
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Best Wholesale Price for NDC 00591-2474

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Dates Price Type
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

00591-2474 Market Analysis and Financial Projection

Market Analysis and Price Projections for the Drug NDC: 00591-2474

To conduct a thorough market analysis and provide price projections for a specific drug identified by its National Drug Code (NDC), it is essential to understand the context in which the drug operates within the pharmaceutical market.

Understanding the National Drug Code (NDC)

The NDC is a unique, three-segment number assigned by the FDA to identify drugs. It includes the labeler code, product code, and package code. For the NDC 00591-2474, each segment provides specific information about the drug, such as the manufacturer, the specific product, and the packaging details[1].

Identifying the Drug

To analyze the market and price projections, we first need to identify the drug associated with the NDC 00591-2474. However, the provided sources do not specify this NDC directly. Typically, you would refer to the FDA's National Drug Code Directory or other pharmaceutical databases to identify the drug.

Market Trends in the Pharmaceutical Industry

The pharmaceutical industry, particularly the biopharma and biotech sectors, is experiencing significant growth and innovation. Here are some key trends that could influence the market analysis:

Biopharma and Biotech Market Growth

The biopharma market is projected to grow at a compound annual growth rate (CAGR) of 7.56% between 2024 and 2029, reaching over $400 billion. The biotech sector is also growing rapidly, with a CAGR of 9.4% between 2021 and 2027[3].

Clinical Trial Innovations

Accelerated clinical trial designs are becoming more prevalent, aiming to reduce timelines and improve efficiency. This shift can impact the development and approval process of new drugs, potentially affecting their market entry and pricing[3].

Regulatory Landscape

The regulatory environment is evolving to accommodate innovative therapies and patient-centered care. Changes in regulatory frameworks can influence the approval and pricing of drugs[3].

Price Projections and Market Analysis

Without specific details on the drug associated with NDC 00591-2474, we can only provide a general framework for how price projections and market analysis might be conducted.

Market Size and Growth

For a drug like the one identified by NDC 00591-2474, market size and growth would depend on factors such as the therapeutic area, competition, and regulatory approvals. For example, in the non-small cell lung cancer (NSCLC) market, immunotherapies and targeted therapies are driving significant growth, with projected sales of $17.5 billion by 2025 for immunotherapies alone[4].

Competitive Landscape

The competitive landscape plays a crucial role in pricing. If the drug is in a highly competitive market, such as NSCLC, where drugs like Keytruda, Opdivo, and Tecentriq dominate, pricing strategies would need to be competitive to gain market share[4].

Patent Expirations and Generics

Patent expirations can significantly impact pricing. For instance, the patent expiration of drugs like Tarceva and Alimta has led to a decline in their sales and an increase in generic sales. This trend could affect the pricing of the drug in question if it faces similar patent issues[4].

Regulatory and Reimbursement Factors

Regulatory approvals and reimbursement policies by health insurance providers and government programs can also influence pricing. For example, the inclusion of a drug in formularies and the level of reimbursement can impact its market adoption and pricing[5].

Key Takeaways

  • Market Growth: The biopharma and biotech industries are experiencing rapid growth, driven by innovations in clinical trials, regulatory changes, and patient-centered care.
  • Competitive Landscape: The pricing of a drug is heavily influenced by the competitive landscape, including the presence of branded and generic competitors.
  • Regulatory Factors: Regulatory approvals and changes in regulatory frameworks can significantly impact the pricing and market adoption of a drug.
  • Patent Expirations: Patent expirations can lead to increased competition from generics, affecting the pricing strategy of the original drug.

FAQs

What is the National Drug Code (NDC) and its significance?

The NDC is a unique three-segment number assigned by the FDA to identify drugs. It includes the labeler code, product code, and package code, providing detailed information about the drug.

How does the competitive landscape affect drug pricing?

The competitive landscape, including the presence of branded and generic competitors, significantly influences drug pricing. In highly competitive markets, drugs must be priced competitively to gain market share.

What impact do patent expirations have on drug pricing?

Patent expirations lead to the entry of generic drugs, which can significantly reduce the sales and pricing of the original branded drug.

How do regulatory changes affect drug pricing?

Regulatory changes, including approvals and reimbursement policies, can impact the pricing and market adoption of a drug. Inclusion in formularies and reimbursement levels are critical factors.

What role do clinical trial innovations play in drug development and pricing?

Accelerated clinical trial designs aim to reduce timelines and improve efficiency, which can affect the development and approval process of new drugs, potentially influencing their market entry and pricing.

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.